Henry Kaw JR. MD in Fullerton, California

Medical School: Sorry, his university is not listed
Graduation Year: 1999
The Primary Medical Specialty for Henry Kaw JR. MD is listed as: Family Practice
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 25
PAC (PECOS ID)#: 3779583117
NPI #: 1215022967
NPI Created On: 10/04/2006
NPI Last Updated Listed as: 02/12/2014
Primary Taxonomy Code: 207Q00000X
License Number:
A95068
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Tagalog, Spanish.

---

Services and Procedures include:

1. Vaccine for influenza for injection into muscle
2. Brief emotional or behavioral assessment
3. New patient office or other outpatient visit, typically 45 minutes
4. New patient office or other outpatient visit, typically 60 minutes
5. Established patient office or other outpatient visit, typically 5 minutes
6. Established patient office or other outpatient visit, typically 15 minutes
7. Established patient office or other outpatient, visit typically 25 minutes
8. Established patient office or other outpatient, visit typically 40 minutes
9. Prolonged office or other outpatient service first hour
10. Advance care planning by the physician or other qualified health care professional
11. Administration of influenza virus vaccine
12. Administration of pneumococcal vaccine
13. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
14. Annual alcohol misuse screening, 15 minutes
15. Annual depression screening, 15 minutes
16. Face-to-face behavioral counseling for obesity, 15 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.